MediCann
  • Home
    • About Us
    • News & Events >
      • News Archive
    • MediCann Blog
  • Find A Doctor
  • Patient Exchange Program
  • The Dosing Project
  • Patient Education
    • Medical Cannabis 101
    • Cannabis & Chronic Pain
    • Cannabis & Cancer
    • Cannabis & Migraines
    • Cannabis & Arthritis
    • Other Studies
  • Industry
    • MJ Hybrid Solutions
    • Resources
    • Research
    • Physicians >
      • MediCann Affiliate Program

Advances in Cannabis Cancer Research

10/20/2022

Comments

 
Picture
I evaluated a couple of patients this week treating cancer with Cannabis and looked at recent news to see what progress is being made in Cannabis cancer research.
 
Early-stage research suggests that Cannabis-derived medicines could be effective in treating various cancers.
 
Although those of us in the Cannabis industry may already be aware of this, the medical community is just coming around to accepting the idea. 
 
Recent experimental treatments and small-scale clinical trials in Europe are showing the efficacy of medicinal Cannabis formulations.
 
THC has primarily been used in cancer treatment for palliative care, to relieve nausea, and stimulate appetite.  However, early-stage research is suggesting that Cannabis, which is more than THC, is also a highly effective treatment for killing cancer cells.
 
So, how does it work?
 
Pre-clinical studies have shown that cannabinoids reduce cancer cell growth and disrupt the blood supply to cancerous cells, including brain tumors, breast cancers and prostate cancer, among others.
 
With, potentially, hundreds of naturally occurring constituents, there is no one magic medical Cannabis bullet in cancer treatment. Cutting edge work using artificial intelligence (AI) is being carried out to analyze Cannabis plant genetics and to determine the best combination of cannabinoids, terpenes, flavonoids, and other constituents to target and optimize the treatment of various cancers.  It’s a many-to-many puzzle; many active ingredients to treat many types of cancers.
 
In pre-clinical studies, Cannabis cancer treatments can be tested through either 2D or 3D cell culture testing. 3D cell cultures allow researchers to recreate specific pathological environments The improvement in 3D cell culture technology has led to the generation of models that encompass more physiological and tissue-specific micro-environments, 
 
Despite advancements in pre-clinical testing, the key to gaining full acceptance in the medical community is real human data from clinical trials.  Currently, there is a small-scale clinical trial on glioblastoma (a brain cancer) in the UK and another trial on liver cancer in the Netherlands.
 
Scientists are also assessing the role of ‘personalized medicines.  Personalized medicine recognizes that we are all physiologically unique and uses individualized DNA sequencing to target treatment.  Personalized medicine is already used in the traditional treatment of cancer. 
 
Combined,. the analysis of AI, 3D Cell Cultures and personalized medicine present a huge opportunity for medical Cannabis and the treatment of cancer. 

Comments

    Author

    Jean Talleyrand, M.D.,
    Chief Medical Officer & Co-Founder - MediCann
    & CESC a nonprofit Cannabis research organization

    Archives

    January 2023
    December 2022
    November 2022
    October 2022
    September 2022
    August 2022
    July 2022
    June 2022
    May 2022
    April 2022
    March 2022
    April 2020
    September 2019
    February 2017
    January 2017
    November 2016
    October 2016
    September 2016

    Categories

    All
    Alternative
    Cannabis
    Medical

    RSS Feed

    Picture
    Picture
    Picture

Services

For Patients
For Providers
For
Industry

Company

Advertise with Us
About

Menu

Support

Contact
Terms of Use
​Mailing Address: MediCann  1336 Willard Street, C • San Francisco, CA 94117

Important Disclaimer!

The information contained in this site does not intend to replace any medical advice or care by a trained physician.
Any use of this information is solely the the responsibility of the user.

© COPYRIGHT 2015. ALL RIGHTS RESERVED.
Photo used under Creative Commons from dstegner1999
  • Home
    • About Us
    • News & Events >
      • News Archive
    • MediCann Blog
  • Find A Doctor
  • Patient Exchange Program
  • The Dosing Project
  • Patient Education
    • Medical Cannabis 101
    • Cannabis & Chronic Pain
    • Cannabis & Cancer
    • Cannabis & Migraines
    • Cannabis & Arthritis
    • Other Studies
  • Industry
    • MJ Hybrid Solutions
    • Resources
    • Research
    • Physicians >
      • MediCann Affiliate Program